Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Azathioprine prescribing in neurology.

× No keyword cloud information.

16 in total

Review 1. Inflammatory myopathies: how to treat the difficult cases.

Authors: F L Mastaglia; P J Zilko
Journal: J Clin Neurosci Date: 2003-01 Impact factor: 1.961

2. Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine.

Authors: A Kandiel; A G Fraser; B I Korelitz; C Brensinger; J D Lewis
Journal: Gut Date: 2005-08 Impact factor: 23.059

3. Risk of cancer in renal-transplant recipients.

Authors: R Hoover; J F Fraumeni
Journal: Lancet Date: 1973-07-14 Impact factor: 79.321

Review 4. Guidelines for prescribing azathioprine in dermatology.

Authors: A V Anstey; S Wakelin; N J Reynolds
Journal: Br J Dermatol Date: 2004-12 Impact factor: 9.302

5. Risk of cancer from azathioprine therapy in multiple sclerosis: a case-control study.

Authors: C Confavreux; P Saddier; J Grimaud; T Moreau; P Adeleine; G Aimard
Journal: Neurology Date: 1996-06 Impact factor: 9.910

6. Azathioprine dosed by thiopurine methyltransferase activity for moderate-to-severe atopic eczema: a double-blind, randomised controlled trial.

Authors: Simon J Meggitt; Janine C Gray; Nick J Reynolds
Journal: Lancet Date: 2006-03-11 Impact factor: 79.321

Review 7. Therapy in myasthenia gravis and Lambert-Eaton myasthenic syndrome.

Authors: John Newsom-Davis
Journal: Semin Neurol Date: 2003-06 Impact factor: 3.420

Review 8. Azathioprine hypersensitivity-like reactions--a case report and a review of the literature.

Authors: S R Knowles; A K Gupta; N H Shear; D Sauder
Journal: Clin Exp Dermatol Date: 1995-07 Impact factor: 3.470

9. A randomized double-blind trial of prednisolone alone or with azathioprine in myasthenia gravis. Myasthenia Gravis Study Group.

Authors: J Palace; J Newsom-Davis; B Lecky
Journal: Neurology Date: 1998-06 Impact factor: 9.910

10. Azathioprine and UVA light generate mutagenic oxidative DNA damage.

Authors: Peter O'Donovan; Conal M Perrett; Xiaohong Zhang; Beatriz Montaner; Yao-Zhong Xu; Catherine A Harwood; Jane M McGregor; Susan L Walker; Fumio Hanaoka; Peter Karran
Journal: Science Date: 2005-09-16 Impact factor: 47.728

1 in total

1. Low-level laser reduces the production of TNF-α, IFN-γ, and IL-10 induced by OVA.

Authors: Rodrigo G Oliveira; Ana P Ferreira; Andréa J Côrtes; Beatriz J Vieira Aarestrup; Luis C Andrade; Fernando M Aarestrup
Journal: Lasers Med Sci Date: 2013-01-22 Impact factor: 3.161

1 in total